There is $30 million in annualized revenue for cost recovery for some 800 facilities that I think Dr. Sharma described. Again, this seems extremely excessive when you think about the 8,000 cases, 5,000 serious ones, that have been considered over the last number of years. It seems very ambitious revenue collection, tax collection, through imposing fees on small companies that are already feeling extremely anxious about heavy-handed health policies that are designed to try to control the products they wish to sell and the consumers who wish to consume them.
I'd like to understand what logic is involved in the $30 million annualized for cost recovery for any program of this scale.